NCT02079324View on ClinicalTrials.gov

Genetically Modified Mesenchymal Stem Cell Theraopeutic Against Head and Neck Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Head and Neck Cancer
Interventions
BIOLOGICAL

GX-051

intratumoral injection

Trial Locations (1)

137-701

Seoul St.Mary's Hospital of the Catholic University of Korea, Seoul

Sponsors

Lead Sponsor

Genexine, Inc.
All Listed Sponsors
lead

Genexine, Inc.

INDUSTRY

NCT02079324 - Genetically Modified Mesenchymal Stem Cell Theraopeutic Against Head and Neck Cancer | Biotech Hunter | Biotech Hunter